Why the study?
Despite extensive genetic research on AF, the genetic factors involved in paroxysmal atrial fibrillation in East Asian populations remain unidentified.
Are rare genetic variants associated with an increased risk of paroxysmal atrial fibrillation in a Japanese population?
Are rare genetic variants associated with an increased risk of paroxysmal atrial fibrillation in a Japanese population?
Whole-exome sequencing identified four novel genes (ZNF785, SMPD3, GFRA4, and LGALS1) significantly associated with paroxysmal atrial fibrillation in a Japanese population, providing new insights into its genetic architecture.
These gene associations with paroxysmal AF are hypothesis-generating; leaves open replication, mechanisms, and clinical utility.
Atrial fibrillation (AF) is the most prevalent arrhythmia in the world and can cause serious complications such as stroke or heart failure. Paroxysmal atrial fibrillation (PAF), a subtype of AF, accounts for approximately 25% of AF cases and is estimated to affect approximately 30 million people worldwide. Despite extensive genetic research on AF, the genetic factors involved in PAF in East Asian (EAS) populations remain unidentified. The aim of our study was to identify genetic factors associated with PAF in the Japanese population, contributing to our understanding of the genetic architecture of AF in Japanese populations. We conducted whole-exome sequencing on a cohort of 1176 PAF individuals and 1172 non-PAF control subjects in a Japanese population. We processed the sequencing data in accordance with the best practices outlined in the Genome Analysis Toolkit (GATK) and conducted gene-based association tests under three variant grouping strategies (masks) using the burden test, SKAT, and SKAT-O. We then performed a meta-analysis of the resulting P-values, which revealed that four genes-ZNF785, SMPD3, GFRA4, and LGALS1-were significantly associated with PAF, representing novel findings. These findings provide new insights into PAF pathogenesis and suggest potential biomarkers for early detection.
No takes yet. Share an insight, caveat, or question.
Sudo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: